Skip to main content

memo - Magazine of European Medical Oncology OnlineFirst articles

03.04.2019 | editorial

memo—publisher’s report 2018

Dr. Alois Sillaber

02.04.2019 | short review Open Access

Tobacco control: prevention and cessation in Europe

Reasons for high smoking prevalence in Europe compared to Australia and North America are low prices of tobacco adjusted for purchasing power and poor smoke-free legislation and enforcement in Central and Eastern Europe. High rates of passive …

Prof. Manfred Neuberger

20.03.2019 | special report Open Access

Direct oral anticoagulants: a treatment option in oncological patients

Venous thrombosis and pulmonary embolism are common complications in patients with active cancer. For many years low molecular weight heparins (LMWH) have been the preferred treatment option for cancer patients, because of their superiority over …

Johannes B. Jaeger, Thomas Jaeger, Ass. Prof. Priv. Doz. Dr. Clemens Feistritzer

21.02.2019 | educational

Educational no.5: next-generation gene panel sequencing

Next-generation sequencing allows the simultaneous interrogation of a large number of genomic targets and is therefore highly suitable for situations, in which mutations in many different genes may have a clinical impact. This short educational …

Wolfgang Kranewitter

21.02.2019 | review Open Access

Resistance to chemotherapy and anti-angiogenic therapy in ovarian cancer

Ovarian cancer (OC) is the foremost lethal gynaecologic malignancy and among the top five deadliest cancers in women. Current treatment comprises a combination therapy of surgery, platinum-based chemotherapy and anti-vascular endothelial growth …

MD, PhD Verena Wieser, MD, PhD Christian Marth

29.01.2019 | case report

Solitary scalp metastatic lesion as a sign of breast cancer recurrence—a case report

Being the most commonly diagnosed cancer in women, breast cancer is the second leading cause of cancer deaths among women in the United States [ 1 ]. With an incidence exceeding 20%, metastatic cutaneous lesions are more often found in women with …

MD Ahmed A. M. Abdelhafeez, MD Wael Ibrahim, MD Wessam Elsherief

15.01.2019 | original report

Investigation of seasonal frequency and pathogens in febrile neutropenia

Febrile neutropenia (FEN) is the most common complication requiring hospitalization and causing mortality in patients with hematological cancer. Also, febrile episodes prolong the duration of hospitalization in neutropenic patients [ 1 ].

Seray Karagöz Özdemir, Utku Iltar, Ozan Salim, Orhan Kemal Yücel, Ramazan Erdem, Özge Turhan, Levent Undar